Establishment of a Three-Dimensional In Vitro Model of Equine Papillomavirus Type 2 Infection.
3D model
EcPV2
horse
hyperplasia
papillomavirus
plaque
raft culture
skin
squamous cell carcinoma
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
19 07 2021
19 07 2021
Historique:
received:
01
06
2021
revised:
06
07
2021
accepted:
14
07
2021
entrez:
10
8
2021
pubmed:
11
8
2021
medline:
19
11
2021
Statut:
epublish
Résumé
There is growing evidence that equine papillomavirus type 2 (EcPV2) infection is etiologically associated with the development of genital squamous cell carcinoma (SCC) and precursor lesions in equids. However, the precise mechanisms underlying neoplastic progression remain unknown. To allow the study of EcPV2-induced carcinogenesis, we aimed to establish a primary equine cell culture model of EcPV2 infection. Three-dimensional (3D) raft cultures were generated from equine penile perilesional skin, plaques and SCCs. Using histological, molecular biological and immunohistochemical methods, rafts versus corresponding natural tissue sections were compared with regard to morphology, presence of EcPV2 DNA, presence and location of EcPV2 gene transcripts and expression of epithelial, mesenchymal and tumor/proliferation markers. Raft cultures from perilesional skin harboring only a few EcPV2-positive (EcPV2+) cells accurately recapitulated the differentiation process of normal skin, whilst rafts from EcPV2+ penile plaques were structurally organized but showed early hyperplasia. Rafts from EcPV2+ SCCs exhibited pronounced hyperplasia and marked dysplasia. Raft levels of EcPV2 oncogene transcription (E6/E7) and expression of tumor/proliferation markers p53, Ki67 and MCM7 expression positively correlated with neoplastic progression, again reflecting the natural situation. Three-dimensional raft cultures accurately reflected major features of corresponding ex vivo material, thus constituting a valuable new research model to study EcPV2-induced carcinogenesis.
Identifiants
pubmed: 34372610
pii: v13071404
doi: 10.3390/v13071404
pmc: PMC8310375
pii:
doi:
Substances chimiques
DNA, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
PLoS One. 2008 Oct 02;3(10):e3313
pubmed: 18836553
J Virol. 1998 Jan;72(1):749-57
pubmed: 9420282
J Invest Dermatol. 1976 Jul;67(1):20-5
pubmed: 778293
Virus Res. 2002 Nov;89(2):249-61
pubmed: 12445664
J Cell Sci. 1981 Aug;50:45-63
pubmed: 7033254
J Gen Virol. 2003 May;84(Pt 5):1055-1062
pubmed: 12692268
Vet Dermatol. 2014 Oct;25(5):475-e77
pubmed: 25041278
J Pathol. 1996 Oct;180(2):175-80
pubmed: 8976877
Methods Mol Med. 2005;119:157-69
pubmed: 16350403
Vet Pathol. 2020 May;57(3):427-431
pubmed: 32180540
Oncotarget. 2017 Mar 7;8(10):16202-16219
pubmed: 26001294
Int J Mol Sci. 2018 Nov 08;19(11):
pubmed: 30413126
J Virol. 2001 Feb;75(3):1565-70
pubmed: 11152531
Stem Cell Res Ther. 2018 Jul 4;9(1):181
pubmed: 29973296
BMC Vet Res. 2019 Oct 22;15(1):356
pubmed: 31640696
Vet Microbiol. 2012 Jul 6;158(1-2):33-41
pubmed: 22397936
Vet Pathol. 2013 Jul;50(4):686-92
pubmed: 23064881
J Vis Exp. 2012 Feb 22;(60):
pubmed: 22395296
Proc Natl Acad Sci U S A. 2013 May 7;110(19):7542-9
pubmed: 23572574
Vet J. 2017 May;223:48-54
pubmed: 28671071
J Clin Virol. 2005 Mar;32 Suppl 1:S7-15
pubmed: 15753007
Nat Protoc. 2017 Feb;12(2):439-451
pubmed: 28125105
Sci Rep. 2018 Oct 18;8(1):15402
pubmed: 30337615
Exp Cell Res. 1979 Oct 1;123(1):25-46
pubmed: 114401
Vet Pathol. 2015 Nov;52(6):1067-72
pubmed: 25967135
Int J Cosmet Sci. 2014 Oct;36(5):485-93
pubmed: 25065839
Nat Rev Microbiol. 2013 Apr;11(4):239-51
pubmed: 23474685
PLoS Pathog. 2017 Dec 27;13(12):e1006781
pubmed: 29281732
Nature. 2016 Jan 28;529(7587):541-5
pubmed: 26789255
Vet Microbiol. 2013 Sep 27;166(1-2):257-62
pubmed: 23845733
Nucleic Acids Res. 2017 Jan 4;45(D1):D499-D506
pubmed: 28053164
Equine Vet J. 2010 Nov;42(8):738-45
pubmed: 21039805
Head Neck Oncol. 2010 Jun 29;2:15
pubmed: 20587061
Am J Pathol. 2012 Feb;180(2):599-607
pubmed: 22189618
PLoS One. 2014 Mar 13;9(3):e91142
pubmed: 24625757
Vet Pathol. 2011 Nov;48(6):1190-4
pubmed: 21282669
Oncotarget. 2016 Oct 4;7(40):64910-64920
pubmed: 27626311
Vet J. 2017 Jul;225:3-8
pubmed: 28720295
Vaccine. 2012 Nov 20;30 Suppl 5:F55-70
pubmed: 23199966
Virology. 2003 Mar 1;307(1):1-11
pubmed: 12667809
J Gen Virol. 2019 Jun;100(6):985-998
pubmed: 31084699
J Virol. 2012 Jun;86(11):6358-64
pubmed: 22457518
Equine Vet J. 2012 Jan;44(1):112-5
pubmed: 21668491
Pathol Res Pract. 2017 Jul;213(7):723-729
pubmed: 28554769
Cancer Med. 2015 Jan;4(1):75-83
pubmed: 25354498